| pubmed-article:15447987 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C1521750 | lld:lifeskim |
| pubmed-article:15447987 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:15447987 | pubmed:issue | 18 Pt 1 | lld:pubmed |
| pubmed-article:15447987 | pubmed:dateCreated | 2004-9-27 | lld:pubmed |
| pubmed-article:15447987 | pubmed:abstractText | The prognosis of hepatocellular carcinoma (HCC) is very poor, particularly in patients with tumors that have invaded the major branches of the portal vein. Combination chemotherapy with intra-arterial 5-fluorouracil and subcutaneous interferon-alpha has shown promising results for such advanced HCC, but it is important to develop the ability to accurately predict chemotherapeutic responses. | lld:pubmed |
| pubmed-article:15447987 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15447987 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15447987 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15447987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15447987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15447987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15447987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15447987 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15447987 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15447987 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:SakonMasatoM | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:NaganoHiroaki... | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:NakamoriShoji... | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:DonoKeizoK | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:UmeshitaKojiK | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:MondenMoritoM | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:MatobaRyoR | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:UenoNorikoN | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:KatoKikuyaK | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:IshiiShinS | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:TakemasaIchir... | lld:pubmed |
| pubmed-article:15447987 | pubmed:author | pubmed-author:KurokawaYukin... | lld:pubmed |
| pubmed-article:15447987 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15447987 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15447987 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:15447987 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15447987 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15447987 | pubmed:pagination | 6029-38 | lld:pubmed |
| pubmed-article:15447987 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:meshHeading | pubmed-meshheading:15447987... | lld:pubmed |
| pubmed-article:15447987 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15447987 | pubmed:articleTitle | Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:15447987 | pubmed:affiliation | Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan. | lld:pubmed |
| pubmed-article:15447987 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15447987 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15447987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15447987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15447987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15447987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15447987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15447987 | lld:pubmed |
